The Journal and Authors retract the 28 June 2016 article cited above for the following reasons provided by the Authors:
In one of our collaborating centers (The People's Hospital of AnQiu City), 38 patients were enrolled in an atorvastatin group. Among them, 26 patients lost to follow-up were categorized and analyzed as “non-recurrence group.” It was a fundamental error and thus we must retract this article. We apologize for any inconvenience caused by the retraction of this article.
Summary
Keywords
chronic subdural hematoma, atorvastatin, Recurrence, CSTH, CT
Citation
Frontiers Editorial Office (2016) Retraction: Atorvastatin May Attenuate Recurrence of Chronic Subdural Hematoma. Front. Neurosci. 10:465. doi: 10.3389/fnins.2016.00465
Received
27 September 2016
Accepted
27 September 2016
Published
07 October 2016
Approved by
Arjan Blokland, Maastricht University, Netherlands
Volume
10 - 2016
Updates
Copyright
© 2016 Frontiers Editorial Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office editorial.office@frontiersin.org
This article was submitted to Neuropharmacology, a section of the journal Frontiers in Neuroscience
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.